Results in line with forecast, page-13

If they list/sell even 50% of Santalis then it should generate around $300m to$500m for TFC, and any of the debt concerns that the shorters keep trying to use as ammunition with evaporate. This will also protect TFC's cash flow, as any costs for the Pharma side of the business will be done via a new entity.

I really hope those shorters get burnt and fried on TFC in the coming months and it's a joke that they are consistently spreading rubbish about the company. It was not that long ago that they claimed the trees had no oil!